Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6 Pt 1
|
pubmed:dateCreated |
1998-8-6
|
pubmed:abstractText |
Growth hormone (GH) treatment of GH-deficient adults increases lean body mass. To investigate this anabolic effect of GH, body composition and postabsorptive and postprandial protein metabolism were measured in 12 GH-deficient adults randomized to placebo or GH treatment. Protein metabolism was measured after an infusion of [1-13C]leucine before and after a standard meal at 0 and 2 mo. After 2 mo, there was an increase in lean body mass in the GH group (P < 0. 05) but no change in the placebo group. In the postabsorptive state, there was increased nonoxidative leucine disappearance (NOLD; a measure of protein synthesis) and leucine metabolic clearance rate and decreased leucine oxidation in the GH group (P < 0.05) but no change in the placebo group. After the meal, there was an increase in NOLD and oxidation in all studies (P < 0.05), but the increase in NOLD, measured as area under the curve, was greater in the GH group (P < 0.05). This study clearly demonstrates for the first time that the increase in protein synthesis in the postabsorptive state after GH treatment of GH-deficient adults is maintained in the postprandial state.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Isotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified,
http://linkedlifedata.com/resource/pubmed/chemical/Human Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Leucine,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
274
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E1050-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9611155-Adult,
pubmed-meshheading:9611155-Body Composition,
pubmed-meshheading:9611155-C-Peptide,
pubmed-meshheading:9611155-Carbon Isotopes,
pubmed-meshheading:9611155-Fatty Acids, Nonesterified,
pubmed-meshheading:9611155-Female,
pubmed-meshheading:9611155-Food,
pubmed-meshheading:9611155-Human Growth Hormone,
pubmed-meshheading:9611155-Humans,
pubmed-meshheading:9611155-Insulin-Like Growth Factor I,
pubmed-meshheading:9611155-Leucine,
pubmed-meshheading:9611155-Male,
pubmed-meshheading:9611155-Metabolic Clearance Rate,
pubmed-meshheading:9611155-Middle Aged,
pubmed-meshheading:9611155-Placebos,
pubmed-meshheading:9611155-Protein Biosynthesis
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults.
|
pubmed:affiliation |
Department of Endocrinology, United Medical and Dental Schools, St. Thomas' Campus, London SE1 7EH, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|